Articles by James Calloway
Coupang Shares Plunge 16% on $266M Q1 Loss from Cyberattack Fallout
Coupang posted a $266M net loss in Q1, citing costs from a data breach. Shares fell 16.6%. Revenue grew 8% to $8.5B, but operating loss widened to $242M.
Cencora Shares Drop 13% on Revenue Outlook Cut Despite Profit Upgrade
Cencora shares tumbled 13.5% after the company slashed its full-year revenue growth forecast, missing quarterly estimates, even as it raised its profit outlook and unveiled a $1 billion buyback.
SolarEdge Shares Tumble as Wider Loss Clouds Revenue Growth
SolarEdge shares dropped 6% after a Q1 adjusted loss exceeded expectations, even as revenue grew 46% to $310.5 million. The company's turnaround faces headwinds from U.S. demand softness and competitive pressure.
Klaviyo Shares Crash 30% as CFO Departure Overshadows Strong Q1 Results
Klaviyo shares fell 30% Wednesday as CFO Amanda Whalen's planned exit overshadowed a Q1 earnings beat and raised 2026 outlook.
TransMedics Shares Slide 23% on Earnings Miss, Despite Revenue Growth
TransMedics shares plunged 23% after Q1 adjusted earnings of $0.30 missed estimates, despite a 21% revenue increase. Profit fell sharply as costs rose.
Oscar Health Shares Surge 5% as Q1 Profit Doubles, 2026 Forecast Maintained
Oscar Health reported Q1 net income of $679M, more than double last year, with revenue up 53% to $4.65B. Shares rose 5.3% as the company reaffirmed its 2026 guidance.
POET Technologies Faces Class Action After Marvell Cancels Celestial AI Orders
POET Technologies is under a securities class action after Marvell canceled all Celestial AI purchase orders. Lead-plaintiff deadline is June 29. Stock at $9.385.
Palantir Drops Despite Record Revenue; Commercial Miss Triggers Selloff
Palantir shares slipped 1.4% to $134.04 despite record quarterly revenue of $1.63B. A $10M miss in U.S. commercial revenue triggered the decline, even as the company raised 2026 guidance.
IonQ Q1 Earnings: Quantum Growth Meets Market Reality
IonQ reports Q1 earnings with revenue of $49.8M and a loss of 46 cents per share. Shares rose 2.6% to $49.26 as investors weigh growth against risks.
Kraft Heinz Q1 Sales Beat Fuels CEO's Turnaround Strategy
Kraft Heinz beat Q1 sales estimates, sending shares up 3.6%. CEO Steve Cahillane's $600M turnaround plan gets an early boost as brand investment ramps up.
CVS Health Upgrades 2026 Profit View as Aetna Cost Controls Boost Q1 Results
CVS Health raised its 2026 profit outlook after a strong Q1, with revenue topping $100 billion and Aetna's medical benefit ratio improving to 84.6%. Shares surged 9%.